PsyTech Global supports our friends at @TheraPsil a Canadian-based coalition of advocates, patients & providers who are working hard to open accessibility to #psilocybin & #psilocybintherapy. Learn more by visiting https://t.co/OJ7wGmS7Ne.
We learned so much from yesterday’s super-informative webinar, “Ketamine Delivery, Patient Success and Ethics: How to Ensure the Best Outcome for Your Patients”. As always, if you missed this one, we’ll let you know when the video replay is posted!
Join us today for a free webinar addressing important issues that affect ketamine providers & patients alike! “Ketamine Delivery, Patient Success and Ethics: How to Ensure the Best Outcome for Your Patients” (May 11 @ 2:30pm EST). Register now: https://t.co/mqZWzDCDlQ
#ketamine
Don’t forget to join us tomorrow for our free webinar! “Ketamine Delivery, Patient Success & Ethics: How to Ensure the Best Outcome for Your Patients” May 11 @ 2:30pm EST. 3 knowledgeable panelists, 1 in-depth & enlightening discussion. See you there! https://t.co/SENA7Q6QcM
2 days left! Join us for an in-depth discussion about issues affecting providers & patients alike. #Ketamine Delivery, Patient Success & Ethics: How to Ensure the Best Outcome for Your Patients May 11, 2:30pm EST. https://t.co/w8l3u1HQ0B Register now:https://t.co/bSxjPPn1k9
As options for #ketaminetherapy increase, so does the need for administering physicians & professionals to understand how they can best serve patients. Join our upcoming free webinar May 11, 2:30 pm EST today.https://t.co/SA8FOKCclv
Check out our newest blog post for a comprehensive list of everything patients should know before choosing a #ketamine clinic, from the various treatment options available to specific questions they should be sure to ask. Read now https://t.co/1KBaq3wa3N
#ketaminetreatment
@reidrobison, CMO of @Novamind_Inc, is an expert on all things related to ketamine-assisted therapy. He is also one of three panelists in our upcoming free webinar (May 11 @ 2:30pm EST). Register today to secure your spot. https://t.co/xCLMKMWXUU
#psychedelics#ketamine
#Ketaminetherapy is rapidly emerging as an increasingly effective & viable option, making the question of proper delivery more important now than ever before. Join our upcoming free webinar May 11@ 2:30pm EST https://t.co/E6hWgVe5MW
#Ketamine clinics are popping up everywhere, but how can patients be sure they are receiving the safest & most effective treatment available? Our upcoming webinar May 11 @ 2:30 pm EST touches on this subject exactly. Register here https://t.co/0tYG4YLmdD
https://t.co/fFCThuHSzW
#Ketamine clinics are popping up everywhere, but how can patients be sure they are receiving the safest & most effective treatment available? Our upcoming free webinar May 11@ 2:30 pm EST touches on this subject exactly. Register to secure your spot. https://t.co/i0ZKM3dK5p
April 19th commemorates “Bicycle Day”, the anniversary of the day #LSD founder Albert Hofmann rode his bicycle home through the streets of Basel, Switzerland while under the influence of his newly discovered and extremely potent drug.
#psytechglobal#bicycleday#psychedelics
Numinus has announced it will acquire Novamind, positioning the combined company as a North American industry leader & bringing both companies closer to their goal of integrating psychedelic-assisted therapy & research into mainstream clinical practice. https://t.co/sGheUU8JDt
Congratulations to @MAPS which celebrated its 36th birthday this past week!
MAPS has worked tirelessly over the past 3 decades to fulfill the need for broader #psychedelicresearch & develop legal options for #psychedelicmedicine. https://t.co/or1KGJeW3r
Exciting announcement for Field Trip HealthLtd. The U.S. Patent and Trademark Office has granted the company a patent for claims related to FT-104. "The patent will provide protection until 2040". Read more 👉https://t.co/5189mYNYbF
#psytechglobal#announcement#psychedelics